Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud

Translated title of the contribution: Use of evidence during the COVID-19 pandemic in Peru, contributions from the National Institute of Health

Karen Huaman Sanchez, Fabiola Huaroto, Catherine Bonilla, Adolfo Aramburú, Javier Morales Barrenechea, Ericson L. Gutiérrez, Maricela Curisinche, Daniel Rojas Bolivar, Diana Maria Gonzales Zurita, Jose Carlos Sánchez-Ramírez, Nora Reyes Puma

Research output: Contribution to journalOriginal Articlepeer-review

Abstract

The COVID-19 pandemics required the countries to take decisions rapidly. Consequently, the National Institute of Health (INS) developed a series of documents of scientific evidence synthesis according to the Ministry of Health’s requirements. Based on these reports, the INS developed recommendations to update normative documents related to COVID-19’s management. This article describes the construction of a new methodology applied by the INS to synthesize scientific evidence during the COVID-19 pandemic. Moreover, it emphasizes the efforts and strategies used to guarantee the methodological quality and the implementation of the GRADE approach. Finally, it provides a short reflection on the limitations and challenges of using evidence to design national public policies in the future.

Translated title of the contributionUse of evidence during the COVID-19 pandemic in Peru, contributions from the National Institute of Health
Original languageSpanish
JournalRevista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
Volume15
DOIs
StateIndexed - Sep 2022

Bibliographical note

Publisher Copyright:
© 2022 Publicado por Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo.

Fingerprint

Dive into the research topics of 'Use of evidence during the COVID-19 pandemic in Peru, contributions from the National Institute of Health'. Together they form a unique fingerprint.

Cite this